BISECCO, Alvino
 Distribuzione geografica
Continente #
EU - Europa 1.743
NA - Nord America 968
AS - Asia 150
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
AF - Africa 1
Totale 2.866
Nazione #
US - Stati Uniti d'America 964
IT - Italia 659
IE - Irlanda 476
GB - Regno Unito 133
CN - Cina 108
AT - Austria 103
DE - Germania 88
UA - Ucraina 73
FR - Francia 67
SE - Svezia 46
TR - Turchia 30
GR - Grecia 29
BE - Belgio 21
FI - Finlandia 21
NL - Olanda 8
PL - Polonia 5
CA - Canada 4
IS - Islanda 4
JP - Giappone 4
IN - India 3
IR - Iran 3
ES - Italia 2
EU - Europa 2
HR - Croazia 2
RS - Serbia 2
RU - Federazione Russa 2
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
DZ - Algeria 1
KR - Corea 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.866
Città #
Dublin 474
Chandler 176
Jacksonville 127
Vienna 103
Ann Arbor 80
Caserta 65
Princeton 56
Roxbury 52
New York 44
Beijing 42
Medford 42
Bremen 41
Rome 37
Naples 33
Napoli 33
Norwalk 23
Brussels 21
Wilmington 21
Nanjing 19
Woodbridge 19
London 17
Milan 17
Cambridge 14
Boardman 12
Des Moines 12
Turin 9
Genoa 8
Jinan 8
San Polo 8
Ashburn 7
Sala Consilina 7
Bologna 6
San Mateo 6
Verona 6
Lanzhou 5
Munich 5
Redwood City 5
Shenyang 5
Wroclaw 5
Auburn Hills 4
Cava De' Tirreni 4
Dearborn 4
Fairfield 4
Gorgonzola 4
Hebei 4
Lappeenranta 4
Nanchang 4
Padova 4
Salerno 4
Santa Maria Capua Vetere 4
Bedford 3
Brescia 3
Buffalo 3
Buscate 3
Falls Church 3
Guangzhou 3
Houston 3
Livorno 3
Mountain View 3
Palermo 3
Parabiago 3
San Vito di Cadore 3
Tokyo 3
Toronto 3
Treviso 3
Turi 3
Amsterdam 2
Augusta 2
Bacoli 2
Castelcovati 2
Cefalù 2
Cercola 2
Cervignano del Friuli 2
Chions 2
Copertino 2
Fisciano 2
Florence 2
Giugliano In Campania 2
Groningen 2
Grosseto 2
Hefei 2
La Spezia 2
Lagnasco 2
Mislata 2
Nettuno 2
Nürnberg 2
Piombino 2
Pisa 2
Reggio Emilia 2
Reggio Nell'emilia 2
Rimini 2
Roccadaspide 2
Santeramo in Colle 2
Sarzana 2
Scafati 2
Sesto al Reghena 2
Shanghai 2
Sinalunga 2
Spinea 2
Taiyuan 2
Totale 1.830
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 432
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 100
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 99
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 97
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 95
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 94
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 88
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 86
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 85
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 79
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 79
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 63
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 61
Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis 59
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 59
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 55
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS) 54
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 52
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 51
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 50
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 48
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 48
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 44
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 43
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 42
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 41
Functional plasticity of the visual system in multiple sclerosis. 40
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 40
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 40
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 39
Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): A longitudinal MRI one-year study 38
Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis 37
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 36
Two Unexpected Cases of Rosacea during Fingolimod Therapy 35
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 35
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 33
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 32
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 31
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 31
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 29
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 28
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 28
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 27
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 27
Listening to the neurological teams for multiple sclerosis: the SMART project 25
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 25
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 24
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 24
Lifespan normative data on rates of brain volume changes 23
Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study 23
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 21
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 20
Readability Analysis of Online Headache and Migraine Information 20
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 18
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 17
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 16
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 15
Psychological resilience explains functional variability across people with multiple sclerosis – Commentary 15
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 14
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 10
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 8
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 8
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 8
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 7
Impact of post-contrast MRI in the definition of active multiple sclerosis 5
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 5
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 4
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 3
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 2
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 2
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 1
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 1
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 1
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 1
Totale 3.076
Categoria #
all - tutte 11.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 13 19
2019/2020305 40 53 12 7 21 19 44 7 39 20 25 18
2020/2021351 16 3 28 36 63 10 55 35 10 26 56 13
2021/2022539 16 24 19 25 127 22 34 25 31 62 38 116
2022/2023883 101 14 25 55 87 58 4 40 445 17 16 21
2023/2024518 37 23 40 77 144 74 63 20 22 17 1 0
Totale 3.076